De schildwachtklier en invasief mammacarcinoom: een nieuwe benadering met minimale chirurgie

info:eu-repo/semantics/publishe

25ème anniversaire de la Clinique du Sein

info:eu-repo/semantics/publishe

Cancer du sein: vers une evolution minimaliste du traitement locorégional.

Breast cancer remains by far the most frequent cancer in women, for that matter it is the most frequent cancer in Belgium affecting both men and women. At the moment, more than 9000 cases are detected annually. The development of screening allows us, fortunately, to detect lesions and stages earlier, in that way locoregional treatmenthas considerably evolved. Since the seventies, radical mastectomy, which consists of the removal ofthe mammary gland, the axillary glands (lymph nodes) and sometimes the pectoral muscle, has been progressively replaced by conservatory treatment. This consists of a wide excision of the tumour with a safety resection margin, followed by a complete removal of the axillary glands (lymph nodes) then followed by a course of external radiotherapy testing treated six weeks daily on a five days week basis. During the nineties, in cases with certain precise indications, the complete axillary gland removal has been replaced by the removal of the first gland chain (lymph node chain) called "sentinel nodes". This technique avoids all morbidity associated to the complete lymph node removal. Finally, very recently, the classic external radiotherapy has been replaced by partial radiotherapy delivered exclusively in a few minutes during the surgical operation. Therefore, we can offer patients with early stage lesions a locoregional treatment carried out in one to two hours with an in-stay hospitalisation of two nights. This new technique manifestly offers a better locoregional control of the illness and very likely enhances (improves) their chances of recovery.SCOPUS: ar.jinfo:eu-repo/semantics/publishe

Le dépistage du cancer du sein: Pourquoi, pour qui et comment ?

info:eu-repo/semantics/publishe

Cancer du sein et ganglion sentinelle: Pourquoi ?Pour qui ?Comment ?

info:eu-repo/semantics/publishe

Présent et futur du diagnostic et de la thérapeutique du cancer du sein: introduction.

The breast cancer in women remains the most frequent with about 30 percent and the rate continues to increase. Happily, parallel to this increase, the diagnosis is done earlier so that the survival is better and treatment becomes less severe. We have several hypotheses for the cause but no one is certain. Risk factors, forecast factors and clinical staging have been established to permit comparable clinical studies and to evaluate treatment efficiency.SCOPUS: ar.jinfo:eu-repo/semantics/publishe

Rôle primordial du gynécologue dans l'indispensable prise en charge multidisciplinaire du cancer du sein

info:eu-repo/semantics/publishe

Radiothérapie per-opératoire: Expérience de plus de 300 patientes

info:eu-repo/semantics/publishe

Le dépistage du cancer du sein.

Regarding the number of female cases (1/9) and incidence increasing, breast cancer remains the greatest public health issue. Presently, the best treatment for our patients is to screen and to treat the disease at an early stage. In our screening process " Mammotest", all women in Belgium, between 50 and 69 years, are called to a certify center every 2 years to have a mammogram. Therefore, the general practitioner has an important roll to play for a better contact in the screening process of the patients.English AbstractJournal Articleinfo:eu-repo/semantics/publishe

Le cancer du sein au masculin.

From 1974 till 1993, 9 patients have been treated in our Hospital for a breast cancer. Compared with the amount of women breast cancers treated, actually near 300 per year, this 0.3% figure seems small, and is lower than that found in the literature (1%). The therapeutic attitude is the same as that proposed for women. The follow-up varied from 9 to 120 months with a mean of 57. Five patients are actually still living without recurrence. One patient presented a local recurrence, one was lost sight off and two died from their cancer. Despite the fact that it was a small group of patients we can say that the symptoms, the clinical staging, the proposed treatments and the survival rate are the same as found in the literature.SCOPUS: ar.jinfo:eu-repo/semantics/publishe